Allianz Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-361,267
| Closed | -$33.6M | – | 2736 |
|
|
2021
Q4 | $33.6M | Buy |
361,267
+243,335
| +206% | +$16M | 0.02% | 589 |
|
|
2021
Q3 | $7.02M | Buy |
117,932
+52,091
| +79% | +$3.08M | 0.01% | 1147 |
|
|
2021
Q2 | $4.49M | Buy |
65,841
+5,170
| +9% | +$337K | ﹤0.01% | 1168 |
|
|
2021
Q1 | $4.21M | Sell |
60,671
-8,138
| -12% | -$626K | ﹤0.01% | 1137 |
|
|
2020
Q4 | $5.29M | Sell |
68,809
-57,288
| -45% | -$4.29M | 0.01% | 1023 |
|
|
2020
Q3 | $9.43M | Buy |
126,097
+5,158
| +4% | +$344K | 0.01% | 787 |
|
|
2020
Q2 | $7.61M | Buy |
120,939
+29,066
| +32% | +$1.6M | 0.01% | 1005 |
|
|
2020
Q1 | $3.86M | Sell |
91,873
-7,213
| -7% | -$331K | 0.01% | 1266 |
|
|
2019
Q4 | $4.5M | Buy |
99,086
+9,643
| +11% | +$456K | ﹤0.01% | 1529 |
|
|
2019
Q3 | $4.09M | Sell |
89,443
-14,620
| -14% | -$822K | ﹤0.01% | 1537 |
|
|
2019
Q2 | $6.1M | Buy |
104,063
+2,876
| +3% | +$149K | 0.01% | 1407 |
|
|
2019
Q1 | $4.54M | Buy |
101,187
+35,731
| +55% | +$1.64M | ﹤0.01% | 1506 |
|
|
2018
Q4 | $2.55M | Buy |
65,456
+49,047
| +299% | +$1.93M | ﹤0.01% | 1665 |
|
|
2018
Q3 | $755K | Buy |
16,409
+1,934
| +13% | +$78.4K | ﹤0.01% | 2300 |
|
|
2018
Q2 | $631K | Sell |
14,475
-90,063
| -86% | -$3.87M | ﹤0.01% | 2339 |
|
|
2018
Q1 | $4.13M | Buy |
+104,538
| New | +$4.07M | ﹤0.01% | 1611 |
|
|
2015
Q4 | – | Sell |
-32,213
| Closed | -$615K | – | 2537 |
|
|
2015
Q3 | $615K | Hold |
32,213
| – | – | ﹤0.01% | 1994 |
|
|
2015
Q2 | $1.5M | Sell |
32,213
-14,213
| -31% | -$617K | ﹤0.01% | 1820 |
|
|
2015
Q1 | $2.03M | Hold |
46,426
| – | – | ﹤0.01% | 1525 |
|
|
2014
Q4 | $1.61M | Buy |
46,426
+23,213
| +100% | +$942K | ﹤0.01% | 1645 |
|
|
2014
Q3 | $973K | Hold |
23,213
| – | – | ﹤0.01% | 1674 |
|
|
2014
Q2 | $1.36M | Sell |
23,213
-2,397
| -9% | -$151K | ﹤0.01% | 1309 |
|
|
2014
Q1 | $1.61M | Hold |
25,610
| – | – | ﹤0.01% | 1278 |
|
|
2013
Q4 | $1.5M | Hold |
25,610
| – | – | ﹤0.01% | 1292 |
|
|
2013
Q3 | $1.35M | Hold |
25,610
| – | – | ﹤0.01% | 1300 |
|
|
2013
Q2 | $1.97M | Buy |
+25,610
| New | +$2.09M | ﹤0.01% | 1205 |
|
Allianz Asset Management's ARNA Position: Q1 2022 in Review
Allianz Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 361,267 shares — an estimated $33.6M sold.
Allianz Asset Management first reported a position in ARNA in Q2 2013 and held it in 26 quarters. The position peaked at $33.6M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Allianz Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Allianz Asset Management sold 361,267 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $33.6M.
- Allianz Asset Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 26 quarters.
- Allianz Asset Management's Arena Pharmaceuticals Inc position peaked at $33.6M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Allianz Asset Management's 13F filing for Q1 2022, filed 13 May 2022.